| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2002PNAS...9914392H |
| P356 | DOI | 10.1073/PNAS.212410199 |
| P932 | PMC publication ID | 137894 |
| P698 | PubMed publication ID | 12381789 |
| P5875 | ResearchGate publication ID | 8653314 |
| P50 | author | Hilde Cheroutre | Q62034648 |
| Herbert C. Morse | Q37375260 | ||
| P2093 | author name string | Mai T N Nguyen | |
| Michael A Teitell | |||
| Samuel W French | |||
| Randolph Wall | |||
| David J Rawlings | |||
| Chen-Feng Qi | |||
| Cindy S Malone | |||
| Katrina K Hoyer | |||
| Mathilde Renard | |||
| Thomas T Su | |||
| Sonja Knoetig | |||
| Devin E Turner | |||
| P2860 | cites work | Identification of the TCL1 gene involved in T-cell malignancies | Q24336607 |
| Akt phosphorylates and regulates the orphan nuclear receptor Nur77 | Q24618410 | ||
| Tcl1 enhances Akt kinase activity and mediates its nuclear translocation | Q24670140 | ||
| Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway | Q57589068 | ||
| Immunophenotypic and Genotypic Analysis of Acquired Immunodeficiency Syndrome-related Non-Hodgkin’s Lymphomas:Correlation with Histologic Features in 36 Cases | Q61473042 | ||
| Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients | Q70921585 | ||
| TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia | Q72030957 | ||
| Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues | Q73726012 | ||
| Non-Hodgkin lymphomas of mice | Q73893212 | ||
| Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes | Q24673023 | ||
| The protooncogene TCL1 is an Akt kinase coactivator | Q28138483 | ||
| The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase | Q28141533 | ||
| The role of TCL1 in human T-cell leukemia | Q28199351 | ||
| Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family | Q28205095 | ||
| Molecular basis of mature T-cell leukemia | Q28205652 | ||
| Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas | Q28207345 | ||
| A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane | Q28217415 | ||
| Cellular survival: a play in three Akts | Q29547806 | ||
| Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1 | Q30811594 | ||
| Signal transduction pathways that regulate the fate of B lymphocytes. | Q33683189 | ||
| Ribosomal S6 kinase signaling and the control of translation | Q33783527 | ||
| An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice | Q33943166 | ||
| AKT plays a central role in tumorigenesis | Q33944165 | ||
| PDK1 regulates growth through Akt and S6K in Drosophila | Q33952857 | ||
| Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression | Q34068006 | ||
| Multiple pathways of ERK activation by G protein-coupled receptors | Q34350687 | ||
| Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. | Q35765016 | ||
| Deregulated expression of TCL1 causes T cell leukemia in mice | Q36011839 | ||
| BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci | Q36322298 | ||
| Burkitt lymphoma in the mouse. | Q36376081 | ||
| TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. | Q36435300 | ||
| Multiple motifs regulate the B-cell-specific promoter of the B29 gene | Q36723592 | ||
| Silencer elements controlling the B29 (Igbeta) promoter are neither promoter- nor cell-type-specific | Q36801835 | ||
| Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. | Q36897460 | ||
| The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase | Q39454531 | ||
| Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation | Q39551585 | ||
| TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma | Q40812531 | ||
| Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis | Q40865206 | ||
| Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma | Q41358124 | ||
| The mRNA 5' cap-binding protein eIF4E and control of cell growth | Q41751015 | ||
| Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice | Q42939811 | ||
| Alterations in fascin-expressing germinal center dendritic cells in neoplastic follicles of B-cell lymphomas | Q46525528 | ||
| Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes | Q47982616 | ||
| T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver. | Q51081086 | ||
| T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance | Q57185252 | ||
| Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1 | Q57562833 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 14392-14397 | |
| P577 | publication date | 2002-10-14 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma | |
| P478 | volume | 99 |
| Q24675006 | Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice |
| Q35077123 | Akt is TCL-ish: implications for B-cell lymphoma. |
| Q36907540 | Antibody-based therapeutics for the treatment of human B cell malignancies |
| Q35622991 | B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders |
| Q52431673 | Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells. |
| Q35849088 | Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation |
| Q35784734 | EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells |
| Q37362114 | Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress |
| Q39766210 | Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b |
| Q24657474 | Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas |
| Q33985141 | Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor |
| Q46042728 | Gene expression patterns in AIDS versus non-AIDS-related diffuse large B-cell lymphoma |
| Q37374649 | Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. |
| Q36384635 | High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia |
| Q34546650 | Identification of nerve growth factor-responsive element of the TCL1 promoter as a novel negative regulatory element |
| Q42078419 | Interaction between TCL1 and Epac1 in the activation of Akt kinases in plasma membranes and nuclei of 8-CPT-2-O-Me-cAMP-stimulated macrophages |
| Q52051782 | Maintained rules of development in a mouse B-cell tumor. |
| Q47215137 | MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells |
| Q33293113 | Mice lacking the Obox6 homeobox gene undergo normal early embryonic development and are fertile |
| Q37791680 | Molecular basis of CLL |
| Q24649526 | Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model |
| Q37457207 | Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome |
| Q30556645 | Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo |
| Q34949637 | Regulation of cell differentiation by the DNA damage response |
| Q90463690 | Somatic and germline genomics in paediatric acute lymphoblastic leukaemia |
| Q28214220 | Sp1 transactivation of the TCL1 oncogene |
| Q39409435 | Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma |
| Q24681203 | T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines |
| Q81600853 | TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state |
| Q35214663 | TCL1: a new drug target in lymphoid and germ-cell malignancies? |
| Q36194235 | TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas |
| Q37692413 | TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice |
| Q24674168 | TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation |
| Q42380774 | Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation |
| Q38305561 | Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1. |
| Q33346593 | The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas |
| Q36858771 | The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma |
| Q41909242 | The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas |
| Q36213981 | The TCL1 family of oncoproteins: co-activators of transformation |
| Q24300764 | The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activity |
| Q83238023 | The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen-telogen transition and affects stem-cell marker CD34 expression |
| Q36125997 | The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. |
| Q35181974 | The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells |
| Q38362950 | The long journey of TCL1 transgenic mice: lessons learned in the last 15 years |
| Q35840178 | Transgenic mice as an in vivo model of lymphomagenesis |
| Q57285472 | Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia |
Search more.